Notably, expression of several potassium channels is modified in bladder cancer vessels vs controls (KCNC4, KCNG4, KCNS2, see Table 4) and in angiosarcoma vs controls (namely KCNJ16, KCNQ2, KCNJ15, KCNJ12, KCNJ1, see Table 5). This evidence concerns the gene KCNS2 and urinary bladder carcinoma.